STOCK TITAN

The Campbell's Company Financials

CPB
FY2025 annual
Revenue $10.3B +6.4% YoY
Net Income $602.0M +6.2% YoY
EPS (Diluted) $2.01 +6.3% YoY
Free Cash Flow $705.0M +5.5% YoY
Source SEC Filings (10-K/10-Q) Data as of May 3, 2026 Currency USD FYE August

The Campbell's Company (CPB) reported $10.3B in revenue for fiscal year 2025, up 6.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CPB FY2025

Cash conversion remains positive, but heavier borrowing and rising interest keep sales growth from rebuilding former profit margins.

Operating cash flow of $1.1B exceeded FY2025 net income of $602M, showing accounting profit is supplemented by noncash expenses and balance-sheet movements rather than simply tracking cash receipts. After capital expenditures of $426M, free cash flow was $705M; the business funds itself, but reinvestment consumes a substantial share of internally generated cash.

Margin pressure sits below gross profit: gross margin was 30.4% in FY2025, while operating margin recovered only to 11.0% after FY2024's trough. SG&A reached $674M versus $598M in FY2021, and depreciation increased too, consistent with a heavier operating cost structure rather than pressure confined to product costs.

The financing posture remains demanding: debt-to-equity was 1.6x and the current ratio was 0.8x, leaving less short-term asset coverage than one-to-one. Despite operating recovery, net margin was 5.9% as interest expense reached $345M, limiting how much operating improvement reached bottom-line profit.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 47 / 100
Financial Health Score 47/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of The Campbell's Company's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
77

The Campbell's Company has an operating margin of 11.0%, meaning the company retains $11 of operating profit per $100 of revenue. This strong profitability earns a score of 77/100, reflecting efficient cost management and pricing power. This is up from 10.4% the prior year.

Growth
49

The Campbell's Company's revenue grew 6.4% year-over-year to $10.3B, a solid pace of expansion. This earns a growth score of 49/100.

Leverage
15

The Campbell's Company has elevated debt relative to equity (D/E of 1.56), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 15/100, reflecting increased financial risk.

Liquidity
11

The Campbell's Company's current ratio of 0.77 is below the typical benchmark, resulting in a score of 11/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
57

The Campbell's Company has a free cash flow margin of 6.9%, earning a moderate score of 57/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
73

The Campbell's Company earns a strong 15.4% return on equity (ROE), meaning it generates $15 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 73/100. This is up from 14.9% the prior year.

Altman Z-Score Distress
1.71

The Campbell's Company scores 1.71, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong
7/9

The Campbell's Company passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
1.88x

For every $1 of reported earnings, The Campbell's Company generates $1.88 in operating cash flow ($1.1B OCF vs $602.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate
3.26x

The Campbell's Company earns $3.26 in operating income for every $1 of interest expense ($1.1B vs $345.0M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$10.3B
YoY+6.4%
5Y CAGR+3.4%
10Y CAGR+2.4%

The Campbell's Company generated $10.3B in revenue in fiscal year 2025. This represents an increase of 6.4% from the prior year.

EBITDA
$1.6B
YoY+10.4%
5Y CAGR+1.7%
10Y CAGR+1.4%

The Campbell's Company's EBITDA was $1.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 10.4% from the prior year.

Net Income
$602.0M
YoY+6.2%
5Y CAGR-18.0%
10Y CAGR-1.0%

The Campbell's Company reported $602.0M in net income in fiscal year 2025. This represents an increase of 6.2% from the prior year.

EPS (Diluted)
$2.01
YoY+6.3%
5Y CAGR-17.8%
10Y CAGR-0.6%

The Campbell's Company earned $2.01 per diluted share (EPS) in fiscal year 2025. This represents an increase of 6.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$705.0M
YoY+5.5%
5Y CAGR-8.5%
10Y CAGR-1.6%

The Campbell's Company generated $705.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 5.5% from the prior year.

Cash & Debt
$132.0M
YoY+22.2%
5Y CAGR-31.2%
10Y CAGR-6.3%

The Campbell's Company held $132.0M in cash against $6.1B in long-term debt as of fiscal year 2025.

Dividends Per Share
$1.54
YoY+4.1%
5Y CAGR+1.9%
10Y CAGR+2.1%

The Campbell's Company paid $1.54 per share in dividends in fiscal year 2025. This represents an increase of 4.1% from the prior year.

Shares Outstanding
298M
YoY-0.1%
5Y CAGR-0.3%
10Y CAGR-0.4%

The Campbell's Company had 298M shares outstanding in fiscal year 2025. This represents a decrease of 0.1% from the prior year.

Margins & Returns

Gross Margin
30.4%
YoY-0.4pp
5Y CAGR-4.1pp
10Y CAGR-4.0pp

The Campbell's Company's gross margin was 30.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.4 percentage points from the prior year.

Operating Margin
11.0%
YoY+0.6pp
5Y CAGR-1.8pp
10Y CAGR-2.1pp

The Campbell's Company's operating margin was 11.0% in fiscal year 2025, reflecting core business profitability. This is up 0.6 percentage points from the prior year.

Net Margin
5.9%
YoY0.0pp
5Y CAGR-12.9pp
10Y CAGR-2.4pp

The Campbell's Company's net profit margin was 5.9% in fiscal year 2025, showing the share of revenue converted to profit. That is unchanged from the prior year.

Return on Equity
15.4%
YoY+0.5pp
5Y CAGR-48.1pp
10Y CAGR-32.8pp

The Campbell's Company's ROE was 15.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.5 percentage points from the prior year.

Capital Allocation

R&D Spending
$100.0M
YoY-2.0%
5Y CAGR+1.5%
10Y CAGR-1.6%

The Campbell's Company invested $100.0M in research and development in fiscal year 2025. This represents a decrease of 2.0% from the prior year.

Share Buybacks
$62.0M
YoY-7.5%
10Y CAGR-12.8%

The Campbell's Company spent $62.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 7.5% from the prior year.

Capital Expenditures
$426.0M
YoY-17.6%
5Y CAGR+7.3%
10Y CAGR+1.1%

The Campbell's Company invested $426.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 17.6% from the prior year.

CPB Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CPB annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$10.0B$10.3B+6.4%$9.6B+3.0%$9.4B+9.3%$8.6B+1.0%$8.5B-2.5%$8.7B+7.2%$8.1B+22.6%$6.6B+13.3%$5.8B-26.7%$8.0B-1.5%$8.1B-2.2%$8.3B+2.7%$8.1B+12.2%$7.2B+0.4%$7.1B
Cost of Revenue$7.1B$7.1B+7.0%$6.7B+3.5%$6.4B+8.5%$5.9B+4.8%$5.7B-0.5%$5.7B+5.1%$5.4B+27.7%$4.2B+24.9%$3.4B-32.5%$5.0B-5.0%$5.3B+0.1%$5.3B+6.6%$5.0B+13.8%$4.4B+2.6%$4.3B
Gross Profit$2.9B$3.1B+5.0%$3.0B+1.9%$2.9B+11.0%$2.6B-6.5%$2.8B-6.3%$3.0B+11.4%$2.7B+13.4%$2.4B-2.8%$2.4B-16.6%$2.9B+5.2%$2.8B-6.4%$3.0B-3.7%$3.1B+9.8%$2.8B-2.7%$2.9B
R&D Expenses$99.0M$100.0M-2.0%$102.0M+10.9%$92.0M+5.7%$87.0M+3.6%$84.0M-9.7%$93.0M+2.2%$91.0M0.0%$91.0M-2.2%$93.0M-11.4%$105.0M-10.3%$117.0M-4.1%$122.0M+28.4%$95.0M-18.1%$116.0M-3.3%$120.0M
SG&A Expenses$662.0M$674.0M-8.5%$737.0M+12.7%$654.0M+6.0%$617.0M+3.2%$598.0M-3.9%$622.0M+2.0%$610.0M+8.3%$563.0M+25.7%$448.0M-22.1%$575.0M-4.3%$601.0M+4.3%$576.0M+2.7%$561.0M-3.3%$580.0M+0.5%$577.0M
Operating Income$1.1B$1.1B+12.4%$1.0B-23.8%$1.3B+12.8%$1.2B-24.7%$1.5B+39.6%$1.1B+13.1%$979.0M-3.1%$1.0B-29.4%$1.4B+49.1%$960.0M-8.9%$1.1B-16.8%$1.3B-14.0%$1.5B+27.6%$1.2B-4.7%$1.2B
Interest Expense$337.0M$345.0M+38.6%$249.0M+32.4%$188.0M-0.5%$189.0M-10.0%$210.0M-39.1%$345.0M-3.1%$356.0M+94.5%$183.0M+59.1%$115.0M0.0%$115.0M+6.5%$108.0M-11.5%$122.0M-9.6%$135.0M+18.4%$114.0M-6.6%$122.0M
Income Tax$188.0M$194.0M+2.1%$190.0M-29.6%$270.0M+23.9%$218.0M-33.5%$328.0M+88.5%$174.0M+15.2%$151.0M+42.5%$106.0M-73.0%$392.0M+37.1%$286.0M+1.1%$283.0M-24.3%$374.0M-9.9%$415.0M+27.7%$325.0M-7.4%$351.0M
Net Income$632.0M$602.0M+6.2%$567.0M-33.9%$858.0M+13.3%$757.0M-24.5%$1.0B-38.5%$1.6B+671.6%$211.0M-19.2%$261.0M-70.6%$887.0M+57.5%$563.0M-15.5%$666.0M-23.1%$866.0M+21.6%$712.0M-8.0%$774.0M-3.9%$805.0M
EPS (Diluted)$2.01+6.3%$1.89-33.7%$2.85+13.5%$2.51-23.7%$3.29-38.6%$5.36+665.7%$0.70-18.6%$0.86-70.2%$2.89+59.7%$1.81-15.0%$2.13-22.3%$2.74+21.8%$2.25-6.6%$2.41-0.4%$2.42

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

CPB Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CPB annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$14.9B-2.2%$15.2B+26.3%$12.1B+1.4%$11.9B+1.3%$11.7B-5.2%$12.4B-5.9%$13.1B-9.5%$14.5B+88.1%$7.7B-1.4%$7.8B-3.0%$8.1B-0.4%$8.1B-2.5%$8.3B+27.5%$6.5B-4.8%$6.9B
Current Assets$2.2B+1.9%$2.2B+6.3%$2.1B+5.0%$2.0B+15.8%$1.7B-28.9%$2.4B+21.3%$2.0B-14.3%$2.3B+20.8%$1.9B-0.4%$1.9B-8.8%$2.1B-0.3%$2.1B-5.5%$2.2B+25.4%$1.8B-9.8%$2.0B
Cash & Equivalents$132.0M+22.2%$108.0M-42.9%$189.0M+73.4%$109.0M+58.0%$69.0M-92.0%$859.0M+2671.0%$31.0M-36.7%$49.0M+32.4%$37.0M-43.9%$66.0M-73.9%$253.0M+9.1%$232.0M-30.3%$333.0M-0.6%$335.0M-30.8%$484.0M
Inventory$1.4B+2.7%$1.4B+7.4%$1.3B+3.6%$1.2B+33.5%$933.0M+7.1%$871.0M+0.9%$863.0M-2.7%$887.0M-1.7%$902.0M-4.0%$940.0M-5.5%$995.0M-1.9%$1.0B+9.6%$925.0M+29.6%$714.0M-6.9%$767.0M
Accounts Receivable$541.0M-7.8%$587.0M+18.8%$494.0M+0.8%$490.0M-9.9%$544.0M+2.6%$530.0M+1.0%$525.0M+2.9%$510.0M-7.3%$550.0M-0.7%$554.0M-0.5%$557.0M-4.8%$585.0M+1.6%$576.0M+12.3%$513.0M-1.2%$519.0M
Goodwill$5.0B-1.7%$5.1B+28.0%$4.0B-0.4%$4.0B-0.1%$4.0B-0.1%$4.0B-0.8%$4.0B+4.0%$3.9B+376.4%$811.0M-64.2%$2.3B-3.5%$2.3B-3.7%$2.4B+5.9%$2.3B+14.1%$2.0B-5.6%$2.1B
Total Liabilities$11.0B-3.9%$11.4B+36.3%$8.4B-1.9%$8.6B-0.2%$8.6B-12.5%$9.8B-18.6%$12.0B-8.5%$13.2B+116.3%$6.1B-3.5%$6.3B-5.9%$6.7B+2.9%$6.5B-8.5%$7.1B+26.3%$5.6B-2.3%$5.8B
Current Liabilities$2.9B-18.7%$3.6B+60.9%$2.2B-23.0%$2.9B+59.1%$1.8B-41.0%$3.1B-9.2%$3.4B-5.8%$3.6B+50.1%$2.4B-6.3%$2.6B-8.9%$2.8B-6.1%$3.0B-8.9%$3.3B+58.6%$2.1B+4.1%$2.0B
Long-Term Debt$6.1B+5.8%$5.8B+28.1%$4.5B+12.6%$4.0B-20.2%$5.0B+0.3%$5.0B-29.7%$7.1B-11.1%$8.0B+219.8%$2.5B+8.0%$2.3B-8.9%$2.5B+13.1%$2.2B-11.8%$2.5B+26.9%$2.0B-17.4%$2.4B
Total Equity$3.9B+2.8%$3.8B+3.6%$3.7B+9.9%$3.3B+5.7%$3.2B+23.0%$2.6B+132.4%$1.1B-19.1%$1.4B-16.7%$1.6B+7.3%$1.5B+10.4%$1.4B-14.4%$1.6B+32.6%$1.2B+35.5%$898.0M-17.5%$1.1B
Retained Earnings$4.7B+2.7%$4.6B+2.7%$4.5B+10.2%$4.0B+8.0%$3.7B+17.3%$3.2B+60.1%$2.0B-10.4%$2.2B-6.8%$2.4B+23.8%$1.9B+9.9%$1.8B+18.3%$1.5B-16.3%$1.8B-81.5%$9.6B+4.3%$9.2B

CPB Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CPB annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow$1.1B$1.1B-4.6%$1.2B+3.7%$1.1B-3.2%$1.2B+14.1%$1.0B-25.9%$1.4B-0.1%$1.4B+7.1%$1.3B+1.3%$1.3B-13.6%$1.5B+23.6%$1.2B+34.1%$899.0M-11.8%$1.0B-9.0%$1.1B-1.9%$1.1B
Capital Expenditures$427.0M$426.0M-17.6%$517.0M+39.7%$370.0M+52.9%$242.0M-12.0%$275.0M-8.0%$299.0M-22.1%$384.0M-5.7%$407.0M+20.4%$338.0M-0.9%$341.0M-10.3%$380.0M+9.5%$347.0M+3.3%$336.0M+4.0%$323.0M+18.8%$272.0M
Free Cash Flow$671.0M$705.0M+5.5%$668.0M-13.6%$773.0M-17.7%$939.0M+23.6%$760.0M-30.7%$1.1B+8.2%$1.0B+12.9%$898.0M-5.5%$950.0M-17.4%$1.1B+39.2%$826.0M+49.6%$552.0M-19.2%$683.0M-14.3%$797.0M-8.4%$870.0M
Investing Cash Flow-$405.0M-$187.0M+94.0%-$3.1B-820.0%-$340.0M-47.8%-$230.0M-45.6%-$158.0M-107.0%$2.3B+1385.0%$153.0M+102.1%-$7.2B-1855.7%-$368.0M-4.0%-$354.0M+41.3%-$603.0M-350.0%-$134.0M+93.8%-$2.2B-566.9%-$323.0M-23.8%-$261.0M
Financing Cash Flow-$436.0M-$919.0M-149.3%$1.9B+357.7%-$723.0M+20.5%-$910.0M+45.5%-$1.7B+44.1%-$3.0B-87.7%-$1.6B-127.4%$5.8B+739.5%-$908.0M+17.4%-$1.1B-99.8%-$550.0M+40.5%-$925.0M-174.8%$1.2B+234.5%-$920.0M-31.4%-$700.0M
Dividends Paid$470.0M$459.0M+3.1%$445.0M-0.4%$447.0M-0.9%$451.0M+2.7%$439.0M+3.1%$426.0M+0.7%$423.0M-0.7%$426.0M+1.4%$420.0M+7.7%$390.0M-1.0%$394.0M+0.8%$391.0M+6.5%$367.0M-1.6%$373.0M-1.3%$378.0M
Share Buybacks$28.0M$62.0M-7.5%$67.0M-52.8%$142.0M-15.0%$167.0M+363.9%$36.0M$0$0-100.0%$86.0M-80.3%$437.0M+205.6%$143.0M-41.4%$244.0M+221.1%$76.0M-50.3%$153.0M-62.9%$412.0M-43.4%$728.0M

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

CPB Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

CPB annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross Margin30.4%-0.4pp30.8%-0.3pp31.2%+0.5pp30.7%-2.5pp33.2%-1.4pp34.5%+1.3pp33.2%-2.7pp35.9%-5.9pp41.8%+5.1pp36.8%+2.4pp34.4%-1.5pp35.9%-2.4pp38.3%-0.9pp39.2%-1.3pp40.4%
Operating Margin11.0%+0.6pp10.4%-3.6pp14.0%+0.4pp13.6%-4.6pp18.2%+5.5pp12.7%+0.7pp12.1%-3.2pp15.3%-9.3pp24.5%+12.5pp12.1%-1.0pp13.0%-2.3pp15.3%-3.0pp18.3%+2.2pp16.1%-0.9pp17.0%
Net Margin5.9%0.0pp5.9%-3.3pp9.2%+0.3pp8.8%-3.0pp11.8%-6.9pp18.7%+16.1pp2.6%-1.4pp4.0%-11.2pp15.2%+8.1pp7.1%-1.2pp8.2%-2.2pp10.5%+1.6pp8.8%-1.9pp10.8%-0.5pp11.3%
Return on Equity15.4%+0.5pp14.9%-8.5pp23.4%+0.7pp22.7%-9.1pp31.8%-31.7pp63.5%+44.4pp19.1%0.0pp19.1%-35.0pp54.2%+17.3pp36.9%-11.3pp48.2%-5.4pp53.7%-4.8pp58.5%-27.7pp86.2%+12.2pp74.0%
Return on Assets4.0%+0.3pp3.7%-3.4pp7.1%+0.7pp6.4%-2.2pp8.5%-4.6pp13.2%+11.6pp1.6%-0.2pp1.8%-9.7pp11.5%+4.3pp7.2%-1.1pp8.3%-2.4pp10.7%+2.1pp8.6%-3.3pp11.8%+0.1pp11.7%
Current Ratio0.77+0.2x0.61-0.3x0.93+0.2x0.68-0.3x0.93+0.2x0.78+0.2x0.58-0.1x0.64-0.2x0.790.0x0.750.0x0.750.0x0.700.0x0.68-0.2x0.86-0.1x0.99
Debt-to-Equity1.560.0x1.52+0.3x1.230.0x1.20-0.4x1.59-0.4x1.95-4.5x6.44+0.6x5.86+4.3x1.530.0x1.52-0.3x1.84+0.4x1.39-0.7x2.09-0.1x2.230.0x2.23
FCF Margin6.9%-0.1pp6.9%-1.3pp8.3%-2.7pp11.0%+2.0pp9.0%-3.7pp12.6%+0.1pp12.5%-1.1pp13.6%-2.7pp16.3%+1.8pp14.4%+4.2pp10.2%+3.5pp6.7%-1.8pp8.5%-2.6pp11.1%-1.1pp12.2%

Note: The current ratio is below 1.0 (0.77), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

What is The Campbell's Company's annual revenue?

The Campbell's Company (CPB) reported $10.3B in total revenue for fiscal year 2025. This represents a 6.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is The Campbell's Company's revenue growing?

The Campbell's Company (CPB) revenue grew by 6.4% year-over-year, from $9.6B to $10.3B in fiscal year 2025.

Is The Campbell's Company profitable?

Yes, The Campbell's Company (CPB) reported a net income of $602.0M in fiscal year 2025, with a net profit margin of 5.9%.

The Campbell's Company (CPB) reported diluted earnings per share of $2.01 for fiscal year 2025. This represents a 6.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

The Campbell's Company (CPB) had EBITDA of $1.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, The Campbell's Company (CPB) had $132.0M in cash and equivalents against $6.1B in long-term debt.

The Campbell's Company (CPB) had a gross margin of 30.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

The Campbell's Company (CPB) had an operating margin of 11.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

The Campbell's Company (CPB) had a net profit margin of 5.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, The Campbell's Company (CPB) paid $1.54 per share in dividends during fiscal year 2025.

The Campbell's Company (CPB) has a return on equity of 15.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

The Campbell's Company (CPB) generated $705.0M in free cash flow during fiscal year 2025. This represents a 5.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

The Campbell's Company (CPB) generated $1.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

The Campbell's Company (CPB) had $14.9B in total assets as of fiscal year 2025, including both current and long-term assets.

The Campbell's Company (CPB) invested $426.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

The Campbell's Company (CPB) invested $100.0M in research and development during fiscal year 2025.

Yes, The Campbell's Company (CPB) spent $62.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

The Campbell's Company (CPB) had 298M shares outstanding as of fiscal year 2025.

The Campbell's Company (CPB) had a current ratio of 0.77 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

The Campbell's Company (CPB) had a debt-to-equity ratio of 1.56 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

The Campbell's Company (CPB) had a return on assets of 4.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

The Campbell's Company (CPB) has an Altman Z-Score of 1.71, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

The Campbell's Company (CPB) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

The Campbell's Company (CPB) has an earnings quality ratio of 1.88x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

The Campbell's Company (CPB) has an interest coverage ratio of 3.26x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

The Campbell's Company (CPB) scores 47 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top